Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelin-A receptor blockade improves postischemic hepatic microhemodynamics.

Dirk Uhlmann1, Sebastian Glasser, Heike Lauer

  • 1Second Department of Surgery, University of Leipzig, Germany. uhld@medizin.uni-leipzig.de

Journal of Cardiovascular Pharmacology
|April 20, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The ACO Curriculum - Advanced Training Program in Surgical Oncology].

Zentralblatt fur Chirurgie·2026
Same author

[Update on Diagnosis-Related Groups (DRG) coding 2026 for general and visceral surgery : From the Department for Health Economics Section of the German Society for General and Visceral Surgery (DGAV)].

Chirurgie (Heidelberg, Germany)·2026
Same author

Publisher Correction: Classical analogue to driven quantum bits based on macroscopic pendula.

Scientific reports·2023
Same author

Classical analogue to driven quantum bits based on macroscopic pendula.

Scientific reports·2023
Same author

Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry.

BMC surgery·2022
Same author

Quality of life and metabolic outcomes after total pancreatectomy and simultaneous islet autotransplantation.

Communications medicine·2022

A novel endothelin-A receptor antagonist protected liver microcirculation from ischemia/reperfusion injury by maintaining blood flow and reducing liver damage. This approach also mitigated harmful platelet-endothelium interactions.

Area of Science:

  • Hepatology
  • Pharmacology
  • Microcirculation Research

Background:

  • Hepatic ischemia/reperfusion (I/R) injury is a significant clinical challenge.
  • Endothelin-A receptor activation contributes to microcirculatory dysfunction during I/R.
  • Targeting endothelin receptors may offer a protective strategy.

Purpose of the Study:

  • To evaluate the protective effect of a selective endothelin-A receptor antagonist (BSF 208075) on hepatic microcirculation following I/R injury.
  • To assess the impact of endothelin receptor blockade on liver enzyme levels and cellular interactions.

Main Methods:

  • A rat model of warm hepatic ischemia (90 minutes) was employed.
  • Groups included sham-operated, untreated ischemic, and BSF 208075 treated ischemic rats.

Related Experiment Videos

  • In-vivo microscopy and liver enzyme assays (AST, ALT) were used for assessment.

    • Main Results:

    • Untreated rats exhibited significant sinusoidal constriction, reduced perfusion, and increased leukocyte/platelet stagnation.
    • Elevated liver enzymes (AST, ALT) were observed 6 hours post-reperfusion in untreated rats.
    • BSF 208075 treatment maintained sinusoidal diameter, increased perfusion, reduced hepatocellular damage, and decreased leukocyte-platelet interactions.

    Conclusions:

    • Selective endothelin-A receptor antagonism effectively mitigates hepatic I/R injury.
    • This therapeutic approach preserves microcirculatory function and reduces liver damage.
    • Endothelin receptor blockade demonstrates a novel role in modulating platelet-endothelium interactions during I/R.